192 related articles for article (PubMed ID: 19909749)
1. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
McMahon BJ; Bruden D; Bruce MG; Livingston S; Christensen C; Homan C; Hennessy TW; Williams J; Sullivan D; Rosen HR; Gretch D
Gastroenterology; 2010 Mar; 138(3):922-31.e1. PubMed ID: 19909749
[TBL] [Abstract][Full Text] [Related]
2. Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.
McMahon BJ; Bruden D; Townshend-Bulson L; Simons B; Spradling P; Livingston S; Gove J; Hewitt A; Plotnik J; Homan C; Espera H; Negus S; Snowball M; Barbour Y; Bruce M; Gounder P
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):431-437.e2. PubMed ID: 27765729
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and risk factors for hepatitis C in Alaska Natives.
McMahon BJ; Hennessy TW; Christensen C; Bruden D; Sullivan DG; Homan C; Deubner H; Bruce MG; Livingston S; Williams J; Gretch DR
Hepatology; 2004 Feb; 39(2):325-32. PubMed ID: 14767985
[TBL] [Abstract][Full Text] [Related]
4. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
5. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy.
Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H
J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.
Goedert JJ; Hatzakis A; Sherman KE; Eyster ME;
J Infect Dis; 2001 Nov; 184(9):1202-5. PubMed ID: 11598846
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of chronic hepatitis C: results of a large, prospective cohort study.
Niederau C; Lange S; Heintges T; Erhardt A; Buschkamp M; Hürter D; Nawrocki M; Kruska L; Hensel F; Petry W; Häussinger D
Hepatology; 1998 Dec; 28(6):1687-95. PubMed ID: 9828236
[TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Hennessy T; Williams J; Livingston S; Gretch D
Liver Int; 2006 Aug; 26(6):643-9. PubMed ID: 16842319
[TBL] [Abstract][Full Text] [Related]
17. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
18. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
Rosenthal E; Pialoux G; Bernard N; Pradier C; Rey D; Bentata M; Michelet C; Pol S; Perronne C; Cacoub P;
J Viral Hepat; 2007 Mar; 14(3):183-8. PubMed ID: 17305884
[TBL] [Abstract][Full Text] [Related]
19. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.
Fransen van de Putte DE; Makris M; Fischer K; Yee TT; Kirk L; van Erpecum KJ; Patch D; Posthouwer D; Mauser-Bunschoten EP
J Hepatol; 2014 Jan; 60(1):39-45. PubMed ID: 23978717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
